These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14632743)

  • 1. Thyrotrophin receptor-specific memory T cell responses require normal B cells in a murine model of Graves' disease.
    Pichurin P; Aliesky H; Chen CR; Nagayama Y; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2003 Dec; 134(3):396-402. PubMed ID: 14632743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
    Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
    Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.
    Kita-Furuyama M; Nagayama Y; Pichurin P; McLachlan SM; Rapoport B; Eguchi K
    Clin Exp Immunol; 2003 Feb; 131(2):234-40. PubMed ID: 12562382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
    Ueki I; Abiru N; Kobayashi M; Nakahara M; Ichikawa T; Eguchi K; Nagayama Y
    Clin Exp Immunol; 2011 Mar; 163(3):309-17. PubMed ID: 21235532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
    Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
    Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine.
    Nagayama Y; Mizuguchi H; Hayakawa T; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2003 Apr; 170(7):3522-7. PubMed ID: 12646613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Hijacking" the thyrotropin receptor: A chimeric receptor-lysosome associated membrane protein enhances deoxyribonucleic acid vaccination and induces Graves' hyperthyroidism.
    Pichurin PN; Chazenbalk GD; Aliesky H; Pichurina O; Rapoport B; McLachlan SM
    Endocrinology; 2004 Dec; 145(12):5504-14. PubMed ID: 15331574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
    Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
    J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization.
    Pichurin PN; Chen CR; Chazenbalk GD; Aliesky H; Pham N; Rapoport B; McLachlan SM
    J Immunol; 2006 Jan; 176(1):668-76. PubMed ID: 16365463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease.
    Kala M; Chen CR; McLachlan SM; Rapoport B; Aliesky H; Chapman HA
    Immunology; 2005 Dec; 116(4):532-40. PubMed ID: 16313367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
    Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
    J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism.
    Pichurin P; Pham N; David CS; Rapoport B; McLachlan SM
    Thyroid; 2006 Dec; 16(12):1221-7. PubMed ID: 17199432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model.
    Ueki I; Abiru N; Kawagoe K; Nagayama Y
    J Endocrinol; 2011 Jun; 209(3):353-7. PubMed ID: 21474590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.
    Saitoh O; Mizutori Y; Takamura N; Yamasaki H; Kita A; Kuwahara H; Nagayama Y
    Clin Exp Immunol; 2005 Sep; 141(3):405-11. PubMed ID: 16045729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
    Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
    Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.
    Chen CR; Aliesky H; Pichurin PN; Nagayama Y; McLachlan SM; Rapoport B
    Endocrinology; 2004 Nov; 145(11):4927-33. PubMed ID: 15284197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles differ markedly in mouse strains that are (or are not) susceptible to hyperthyroidism induced using thyrotropin receptor-expressing adenovirus.
    Chen CR; Abbud R; Wang C; Tan Y; Rapoport B; McLachlan SM
    Thyroid; 2005 Nov; 15(11):1229-37. PubMed ID: 16356085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
    Seetharamaiah GS; Land KJ
    Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.